CNTA logoCNTA
Centessa Pharmaceuticals PLC - ADR

278
Loading...
Loading...
News
all
press releases
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock?
Zacks·3mo ago
News Placeholder
More News
News Placeholder
Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet
Zacks·3mo ago
News Placeholder
The Lustgarten Foundation Appoints Two New Board Members
The Lustgarten Foundation Appoints Two New Board Members The Lustgarten Foundation Appoints Two New Board Members PR Newswire WOODBURY, N.Y., June 13, 2024 Richard Barakat, MD, and Aaron Kantoff join...
PR Newswire·1y ago
News Placeholder
CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. The post...
InvestorPlace·1y ago
News Placeholder
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4Related Stocks: CNTA...
GuruFocus·1y ago
News Placeholder
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...
Globe Newswire·1y ago
News Placeholder
Centessa Pharmaceuticals plc (CNTA, $11.1) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024
This indicator may be signaling CNTA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·1y ago
News Placeholder
Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
Related Stocks: CNTA...
GuruFocus·1y ago
News Placeholder
Centessa Pharmaceuticals plc (CNTA, $10.76) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024
This indicator may be signaling that CNTA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Centessa Pharmaceuticals plc (CNTA, $11.17) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024
This indicator may be signaling CNTA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks·1y ago

Latest CNTA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.